EXPONENT INC
For the period ended Apr 4, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 4, 2025 · Filed May 9, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information on the Company’s repurchases of the Company’s common stock for the three months ended April 4, 2025:
| (In thousands, except price per share) · TotalNumberof SharesPurchased · AveragePricePaid PerShare · TotalNumber ofSharesPurchasedas Part ofPubliclyAnnouncedPrograms · ApproximateDollar Valueof Shares ThatMay Yet BePurchasedUnder thePrograms (1) | |||||
|---|---|---|---|---|---|
| January 4 to January 31 | - | $ | - | - | $94,290 |
| February 1 to February 28 | - | - | - | 94,290 | |
| March 1 to April 4 | 65 | 77.31 | 65 | 89,290 | |
| Total | 65 | $77.31 | 65 | $89,290 | |
(1)
On February 22, 2022, the Company’s Board of Directors announced $150,000,000 for repurchase of the Company’s common stock. On February 1, 2024, the Company’s Board of Directors announced and additional $61,610,000 for repurchase of the Company’s common stock. These repurchase programs have no expiration dates.
Repurchases of the Company’s common stock were affected pursuant to a repurchase program authorized by the Company’s Board of Directors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.